← Back to headlines
Novartis and Antares Partner on Cancer Drug Development in $1.9B Deal
Novartis and Antares have announced a collaboration to develop cancer drugs, with the deal potentially valued at up to $1.9 billion.
24 Jun, 14:06 — 24 Jun, 14:06
Sources
Showing 1 of 1 sources
